For example, our study evaluated the population of non-small cell lung cancer patients who did not distinguish whether they tested for PD-L1 expression status or not, and the conclusion was that it was not cost-effective compared with chemotherapy regimen. Here, CD274 is linked to non-small cell lung carcinoma.